ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

21 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

02 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

09 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

30 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

04 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

23 8 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

10 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

01 8 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 6 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 5 2023 16:01:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 5 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 5 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 3 2023 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 3 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 1 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 11 2022 16:05:01 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 10 2022 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 9 2022 09:00:01 提供 Nasdaq GlobeNewswire